Business Description
Cassava Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US14817C1071
Compare
Compare
Traded in other countries / regions
SAVA.USAPX91.GermanySAVA.Mexico IPO Date
2000-07-14Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -112.6 | |||||
| 3-Year EPS without NRI Growth Rate | -109.3 | |||||
| 3-Year FCF Growth Rate | -112.1 | |||||
| 3-Year Book Growth Rate | 7.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.82 | |||||
| 9-Day RSI | 44.52 | |||||
| 14-Day RSI | 45.92 | |||||
| 6-1 Month Momentum % | 41.3 | |||||
| 12-1 Month Momentum % | -15.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.13 | |||||
| Quick Ratio | 9.13 | |||||
| Cash Ratio | 8.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.2 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -53.8 | |||||
| ROA % | -49.89 | |||||
| ROIC % | -442.26 | |||||
| ROC (Joel Greenblatt) % | -460.26 | |||||
| ROCE % | -58.61 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 6.29 | |||||
| Price-to-Tangible-Book | 6.3 | |||||
| EV-to-EBIT | -6.87 | |||||
| EV-to-EBITDA | -6.97 | |||||
| EV-to-Forward-Revenue | 4.02 | |||||
| EV-to-FCF | -8.83 | |||||
| Price-to-Net-Current-Asset-Value | 7.51 | |||||
| Price-to-Net-Cash | 8.1 | |||||
| Earnings Yield (Greenblatt) % | -14.56 | |||||
| FCF Yield % | -9.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SAVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cassava Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.32 | ||
| Beta | -1.17 | ||
| Volatility % | 38.29 | ||
| 14-Day RSI | 45.92 | ||
| 14-Day ATR ($) | 1.598158 | ||
| 20-Day SMA ($) | 21.423 | ||
| 12-1 Month Momentum % | -15.7 | ||
| 52-Week Range ($) | 12.3202 - 32.1 | ||
| Shares Outstanding (Mil) | 43.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cassava Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cassava Sciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cassava Sciences Inc Frequently Asked Questions
What is Cassava Sciences Inc(SAVA)'s stock price today?
The current price of SAVA is $20.49. The 52 week high of SAVA is $32.10 and 52 week low is $12.32.
When is next earnings date of Cassava Sciences Inc(SAVA)?
The next earnings date of Cassava Sciences Inc(SAVA) is 2024-05-01 Est..
Does Cassava Sciences Inc(SAVA) pay dividends? If so, how much?
Cassava Sciences Inc(SAVA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers